682 related articles for article (PubMed ID: 33471729)
1. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
[TBL] [Abstract][Full Text] [Related]
2. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
[TBL] [Abstract][Full Text] [Related]
3. Sublingual Estradiol Is Associated with Higher Estrone Concentrations than Transdermal or Injectable Preparations in Transgender Women and Gender Nonbinary Adults.
Cirrincione LR; Winston McPherson G; Rongitsch J; Sadilkova K; Drees JC; Krasowski MD; Dickerson JA; Greene DN
LGBT Health; 2021; 8(2):125-132. PubMed ID: 33439749
[No Abstract] [Full Text] [Related]
4. Serum Hormone Concentrations in Transgender Youth Receiving Estradiol.
Sumerwell C; Carlin K; Walsh E; Hodax JK
Endocr Pract; 2024 Feb; 30(2):155-159. PubMed ID: 38029927
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Subcutaneous and Intramuscular Estradiol Regimens as Part of Gender-Affirming Hormone Therapy.
Herndon JS; Maheshwari AK; Nippoldt TB; Carlson SJ; Davidge-Pitts CJ; Chang AY
Endocr Pract; 2023 May; 29(5):356-361. PubMed ID: 36868378
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
7. Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen.
Scheres LJJ; Selier NLD; Nota NM; van Diemen JJK; Cannegieter SC; den Heijer M
J Thromb Haemost; 2021 Apr; 19(4):1029-1037. PubMed ID: 33527671
[TBL] [Abstract][Full Text] [Related]
8. Gender-Affirming Hormone Therapy and Bone Health: Do Different Regimens Influence Outcomes in Transgender Adults? A Narrative Review and Call for Future Studies.
Cirrincione LR; Narla RR
J Appl Lab Med; 2021 Jan; 6(1):219-235. PubMed ID: 33432334
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Gender-Affirming Hormone Therapy Requirements.
Fernandez JD; Kendjorsky K; Narla A; Villasante-Tezanos AG; Tannock LR
LGBT Health; 2019 Apr; 6(3):101-106. PubMed ID: 30810452
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Gender-Affirming Hormone Therapy on Serum Creatinine in Transgender Individuals.
Maheshwari A; Dines V; Saul D; Nippoldt T; Kattah A; Davidge-Pitts C
Endocr Pract; 2022 Jan; 28(1):52-57. PubMed ID: 34474185
[TBL] [Abstract][Full Text] [Related]
11. Low estrogen doses normalize testosterone and estradiol levels to the female range in transgender women.
Cunha FS; Domenice S; Sircili MHP; Mendonca BB; Costa EMF
Clinics (Sao Paulo); 2018; 73():e86. PubMed ID: 29723345
[TBL] [Abstract][Full Text] [Related]
12. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.
Liu Y; Xin Y; Qi J; Wang H; Hong T; Yang X; Li B; Chang X; Knudson G; Zhao Z; Pan B
J Sex Med; 2020 Nov; 17(11):2291-2298. PubMed ID: 32868262
[TBL] [Abstract][Full Text] [Related]
13. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
McFarlane T; Zajac JD; Cheung AS
Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C-Based eGFR Changes during Gender-Affirming Hormone Therapy in Transgender Individuals.
van Eeghen SA; Wiepjes CM; T'Sjoen G; Nokoff NJ; den Heijer M; Bjornstad P; van Raalte DH
Clin J Am Soc Nephrol; 2023 Dec; 18(12):1545-1554. PubMed ID: 37678248
[TBL] [Abstract][Full Text] [Related]
15. Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.
Mullins ES; Geer R; Metcalf M; Piccola J; Lane A; Conard LAE; Mullins TLK
Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33753543
[TBL] [Abstract][Full Text] [Related]
16. Prescription Patterns and Testosterone Concentrations Achieved With AndroForte 5% Testosterone Cream in Transgender and Gender Diverse Individuals.
Nolan BJ; Zwickl S; Locke P; Simpson S; Li L; Zajac JD; Cheung AS
J Sex Med; 2022 Jun; 19(6):1049-1054. PubMed ID: 35365401
[TBL] [Abstract][Full Text] [Related]
17. Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial.
Dijkman BAM; Helder D; Boogers LS; Gieles NC; van Heesewijk JO; Slaa ST; Liberton NPTJ; Wiepjes CM; de Blok CJM; den Heijer M; Dreijerink KMA
BMC Pharmacol Toxicol; 2023 Dec; 24(1):80. PubMed ID: 38124194
[TBL] [Abstract][Full Text] [Related]
18. Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy.
Collet S; Gieles NC; Wiepjes CM; Heijboer AC; Reyns T; Fiers T; Lapauw B; den Heijer M; T'Sjoen G
J Clin Endocrinol Metab; 2023 Jan; 108(2):331-338. PubMed ID: 36201493
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]